Magnesium and Potassium: study protocols
8 study groups took Magnesium together with Potassium. These are the doses the studies gave. They are not a recommendation.
Fewer than 5 study groups in one unit match, too few to draw the chart.
Commonly used together
3 of 8 study groups took Magnesium and Potassium with something else, but nothing that 3 or more different studies gave.
8 study groups
| Study | ||||
|---|---|---|---|---|
| A randomized, controlled trial of oral sulfate solution versus polyethylene glycol for bowel preparation for colonoscopy 2025 · Group A (OSS) · Men and women aged 18–70 years undergoing screening, surveillance, or diagnostic colonoscopy | 1.6 g | 3.13 g | 1 day | 324 |
| Effects of magnesium and potassium supplementation on insomnia and sleep hormones in patients with diabetes mellitus 2024 · T4: Magnesium + potassium · Men and women aged 19–65 with diabetes and insomnia | 500 mg | 500 mg | 60 days | 73 |
| Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. Magnesium in Cardiac Arrhythmias (MAGICA) Investigators 1997 · active therapy · Patients with frequent ventricular arrhythmias (>720 ventricular premature beats per 24 hours); age and sex not specified | 6 mmol | 12 mmol | 3 weeks | — |
| Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study 1990 · potassium with magnesium · Adults with mild hypertension (diastolic blood pressure less than 110 mm Hg) | 20 mmol | 60 mmol | 32 weeks | — |
| Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake 1998 · all three minerals together · Normotensive women, mean age 39, with low habitual intake of potassium, calcium, and magnesium | 14 mmol | 40 mmol | 16 weeks | — |
| Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension 2006 · magnesium potassium supplementation · Patients with essential hypertension; age and sex not reported | 70.8 mg | 217 mg | 4 weeks | 35 |
| Electrocardiographic changes induced by inhaled salbutamol after treatment with bendrofluazide: effects of replacement therapy with potassium, magnesium and triamterene 1990 · bendrofluazide plus potassium plus magnesium · 12 normal subjects; age and sex not reported | 24 mmol | 24 mmol | 5 days | 12 |
| Dietary intervention with a specific micronutrient combination for the treatment of patients with cardiac arrhythmias: the impact on insulin resistance and left ventricular function 2018 · verum group · Adults aged 18–75 with cardiac arrhythmias (ventricular or supraventricular premature beats or supraventricular tachycardia); patients with cardiovascular disorders, often including hypertension or coronary artery disease | 146 mg | 469 mg | 6 weeks | 29 |